Ryan Soose
Otolaryngology · Seven Fields, PANPI 1265646681
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $93,469 of the $133,684 with a category attached, or 69.9%. Inspire Medical Systems, Inc. accounts for 97.3% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $41,747, 5.0 times the $8,295 reported in 2019. Among otolaryngology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $1104.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$130K
- Smith+Nephew$3K
- ZOLL Respicardia, Inc.$900
Across 54 payments — averaging $2966.69 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Inspire Medical Systems, Inc.$160K
What the payments were for
- Consulting fees$93,46970%
- Speaking & faculty fees$18,50014%
- Travel & lodging$13,35710%
- Food & beverage$4,5583%
- Education$3,8003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 115 | $130,085 |
| Smith+Nephew | 5 | $2,699 |
| ZOLL Respicardia, Inc. | 1 | $900 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$133,684 in reported general payments places this provider in the 95th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Modafinil | 28 | $934 |
| Azelastine Hcl | 17 | $830 |
| Ipratropium Bromide | 29 | $743 |
| Eszopiclone | 13 | $327 |
| Fluticasone Propionate | 25 | $286 |
| Trazodone Hcl | 47 | $250 |
| Montelukast Sodium | 23 | $230 |
| Famotidine | 23 | $188 |
| Zolpidem Tartrate | 35 | $178 |
| Mupirocin | 22 | $160 |
| Zaleplon | 15 | $112 |
| Clonazepam | 23 | $79 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Seven Fields
- Nancy SnydermanPhiladelphia$4.5M
- David YenBethlehem$1.4M
- David KennedyPhiladelphia$603K
- Stella LeePittsburgh$438K
- James PalmerPhiladelphia$331K
- Mathew NagorskyPhiladelphia$95K
- Noam CohenPhiladelphia$76K
- Nithin AdappaPhiladelphia$72K
- Matthew SpectorPittsburgh$56K
- Umamaheswar DuvvuriPittsburgh$48K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.